EXECUTIVE ENGAGEMENTS
POOL
8132
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
1138
Interactions with Platform & by Email
PARTICIPANTS
244
Unique # Participated
VALIDATIONS
86
Responses Validated*
COMPANIES
76
Responses Validated*
* Login for a full stack data experience
DATE
OCT 2022
TABLES
122
PAGES
212
EDITION
15
PRICE
USD 5600
CODE
MCP-1747
*Engagement stats are ongoing and dynamic
RESEARCH MODULES
EXECUTIVES
HIGHLIGHTS & REPORT INDEX
What`s New for 2022?
» Global competitiveness and key competitor percentage market shares
» Market presence across multiple geographies - Strong/Active/Niche/Trivial
» Online interactive peer-to-peer collaborative bespoke updates
» Access to our digital archives and MarketGlass Research Platform
» Complimentary updates for one year
Amid the COVID-19 crisis, the global market for Prostate Cancer Therapeutics estimated at US$12.3 Billion in the year 2020, is projected to reach a revised size of US$19.1 Billion by 2027, growing at a CAGR of 6.5% over the analysis period 2020-2027. Hormone Therapy, one of the segments analyzed in the report, is projected to record a 6.7% CAGR and reach US$15.1 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Targeted Therapy segment is readjusted to a revised 5.8% CAGR for the next 7-year period.
The Prostate Cancer Therapeutics market in the U.S. is estimated at US$3.6 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$3.4 Billion by the year 2027 trailing a CAGR of 6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6% and 5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5% CAGR.
In the global Chemotherapy segment, USA, Canada, Japan, China and Europe will drive the 5.5% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$659.3 Million in the year 2020 will reach a projected size of US$960.3 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$2.2 Billion by the year 2027.
SELECT PLAYERS
AbbVie Inc.; Allergan plc; Amgen Inc.; Astellas Pharma Inc.; AstraZeneca Plc.; Bayer AG; Bristol-Myers Squibb Company; Debiopharm Group; Endo Pharmaceuticals Inc.; F. Hoffmann-La Roche Ltd.; Genentech Inc.; GlaxoSmithKline Plc; Janssen Biotech Inc.; Novartis AG; Pfizer Inc.; Progenics Pharmaceuticals Inc.; Sanofi S.A.; Spectrum Pharmaceuticals Inc.; Takeda Pharmaceutical Company Limited; TOLMAR Pharmaceuticals Inc.
SEGMENTS
» Therapy Type (Hormone Therapy, Targeted Therapy, Chemotherapy, Targeted Therapy) » Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online sales, Other Distribution Channels)
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
TABLE OF CONTENTS
| I. METHODOLOGY |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Influencer Market Insights |
| World Market Trajectories |
| Impact of Covid-19 and a Looming Global Recession |
| Recent Market Activity |
| An Insight in the Global Market for Prostate Cancer Diagnostics and Therapeutics |
| Rising Incidence of Prostate Cancer: Cornerstone for the Market |
| Current & Future Analysis |
| Developing Countries Turbo Charge Future Market Growth |
| An Insight into the Castration-Resistant Prostate Cancer Therapeutics Market |
| Hormone Therapies to Dominate Global Prostate Cancer Therapeutics Market |
| Key Prostate Cancer Hormone Therapy Drugs & Companies: 2017 |
| Targeted Therapy - The New Frontier of Cancer Treatment |
| Radiotherapy - Gaining Prominence |
| Metastatic Prostate Cancer - Apt for Precision Oncology |
| Launch of Generic Drugs to Place Established Players in Jeopardy |
| Demographics & Lifestyles Raise the Risk of Prostate Cancer |
| Select General Risk Factors and their Relative Risk Rate in Prostate Cancer |
| Small Cap Companies: A Target of Private Capital Financing |
| Cost Analysis of Currently Available Treatment |
| Growth Drivers |
| Growth Restraints |
| Pipeline of Drugs in Clinical Trials |
| Innovations & Advancements |
| Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E) |
| Prostate Cancer Therapeutics – Global Key Competitors Percentage Market Share in 2022 (E) |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Recent Past, Current & Future Analysis for Prostate Cancer Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Prostate Cancer Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Prostate Cancer Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Hormone Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Hormone Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Hormone Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Targeted Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Targeted Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Targeted Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Chemotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Chemotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Chemotherapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Hospital Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Retail Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Online Sales by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Online Sales by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Online Sales by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Other Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Other Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Other Distribution Channels by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
| World Prostate Cancer Therapeutics Market Analysis of Annual Sales in US$ Million for Years 2012 through 2027 |
| III. MARKET ANALYSIS |
| UNITED STATES |
| Prostate Cancer Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E) |
| USA Recent Past, Current & Future Analysis for Prostate Cancer Therapeutics by Therapy Type - Hormone Therapy, Targeted Therapy and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Prostate Cancer Therapeutics by Therapy Type - Hormone Therapy, Targeted Therapy and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Prostate Cancer Therapeutics by Therapy Type - Percentage Breakdown of Value Sales for Hormone Therapy, Targeted Therapy and Chemotherapy for the Years 2012, 2021 & 2027 |
| USA Recent Past, Current & Future Analysis for Prostate Cancer Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Prostate Cancer Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Prostate Cancer Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels for the Years 2012, 2021 & 2027 |
| CANADA |
| Canada Recent Past, Current & Future Analysis for Prostate Cancer Therapeutics by Therapy Type - Hormone Therapy, Targeted Therapy and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Prostate Cancer Therapeutics by Therapy Type - Hormone Therapy, Targeted Therapy and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Prostate Cancer Therapeutics by Therapy Type - Percentage Breakdown of Value Sales for Hormone Therapy, Targeted Therapy and Chemotherapy for the Years 2012, 2021 & 2027 |
| Canada Recent Past, Current & Future Analysis for Prostate Cancer Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Prostate Cancer Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Prostate Cancer Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels for the Years 2012, 2021 & 2027 |
| JAPAN |
| Prostate Cancer Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E) |
| Japan Recent Past, Current & Future Analysis for Prostate Cancer Therapeutics by Therapy Type - Hormone Therapy, Targeted Therapy and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Prostate Cancer Therapeutics by Therapy Type - Hormone Therapy, Targeted Therapy and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Prostate Cancer Therapeutics by Therapy Type - Percentage Breakdown of Value Sales for Hormone Therapy, Targeted Therapy and Chemotherapy for the Years 2012, 2021 & 2027 |
| Japan Recent Past, Current & Future Analysis for Prostate Cancer Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Prostate Cancer Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Prostate Cancer Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels for the Years 2012, 2021 & 2027 |
| CHINA |
| Prostate Cancer Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E) |
| China Recent Past, Current & Future Analysis for Prostate Cancer Therapeutics by Therapy Type - Hormone Therapy, Targeted Therapy and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Prostate Cancer Therapeutics by Therapy Type - Hormone Therapy, Targeted Therapy and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Prostate Cancer Therapeutics by Therapy Type - Percentage Breakdown of Value Sales for Hormone Therapy, Targeted Therapy and Chemotherapy for the Years 2012, 2021 & 2027 |
| China Recent Past, Current & Future Analysis for Prostate Cancer Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Prostate Cancer Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Prostate Cancer Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels for the Years 2012, 2021 & 2027 |
| EUROPE |
| Prostate Cancer Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E) |
| Europe Recent Past, Current & Future Analysis for Prostate Cancer Therapeutics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Prostate Cancer Therapeutics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Prostate Cancer Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2021 & 2027 |
| Europe Recent Past, Current & Future Analysis for Prostate Cancer Therapeutics by Therapy Type - Hormone Therapy, Targeted Therapy and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Prostate Cancer Therapeutics by Therapy Type - Hormone Therapy, Targeted Therapy and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Prostate Cancer Therapeutics by Therapy Type - Percentage Breakdown of Value Sales for Hormone Therapy, Targeted Therapy and Chemotherapy for the Years 2012, 2021 & 2027 |
| Europe Recent Past, Current & Future Analysis for Prostate Cancer Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Prostate Cancer Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Prostate Cancer Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels for the Years 2012, 2021 & 2027 |
| FRANCE |
| Prostate Cancer Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E) |
| France Recent Past, Current & Future Analysis for Prostate Cancer Therapeutics by Therapy Type - Hormone Therapy, Targeted Therapy and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Prostate Cancer Therapeutics by Therapy Type - Hormone Therapy, Targeted Therapy and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Prostate Cancer Therapeutics by Therapy Type - Percentage Breakdown of Value Sales for Hormone Therapy, Targeted Therapy and Chemotherapy for the Years 2012, 2021 & 2027 |
| France Recent Past, Current & Future Analysis for Prostate Cancer Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Prostate Cancer Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Prostate Cancer Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels for the Years 2012, 2021 & 2027 |
| GERMANY |
| Prostate Cancer Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E) |
| Germany Recent Past, Current & Future Analysis for Prostate Cancer Therapeutics by Therapy Type - Hormone Therapy, Targeted Therapy and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Prostate Cancer Therapeutics by Therapy Type - Hormone Therapy, Targeted Therapy and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Prostate Cancer Therapeutics by Therapy Type - Percentage Breakdown of Value Sales for Hormone Therapy, Targeted Therapy and Chemotherapy for the Years 2012, 2021 & 2027 |
| Germany Recent Past, Current & Future Analysis for Prostate Cancer Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Prostate Cancer Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Prostate Cancer Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels for the Years 2012, 2021 & 2027 |
| ITALY |
| Italy Recent Past, Current & Future Analysis for Prostate Cancer Therapeutics by Therapy Type - Hormone Therapy, Targeted Therapy and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Prostate Cancer Therapeutics by Therapy Type - Hormone Therapy, Targeted Therapy and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Prostate Cancer Therapeutics by Therapy Type - Percentage Breakdown of Value Sales for Hormone Therapy, Targeted Therapy and Chemotherapy for the Years 2012, 2021 & 2027 |
| Italy Recent Past, Current & Future Analysis for Prostate Cancer Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Prostate Cancer Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Prostate Cancer Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels for the Years 2012, 2021 & 2027 |
| UNITED KINGDOM |
| Prostate Cancer Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E) |
| UK Recent Past, Current & Future Analysis for Prostate Cancer Therapeutics by Therapy Type - Hormone Therapy, Targeted Therapy and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Prostate Cancer Therapeutics by Therapy Type - Hormone Therapy, Targeted Therapy and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Prostate Cancer Therapeutics by Therapy Type - Percentage Breakdown of Value Sales for Hormone Therapy, Targeted Therapy and Chemotherapy for the Years 2012, 2021 & 2027 |
| UK Recent Past, Current & Future Analysis for Prostate Cancer Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Prostate Cancer Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Prostate Cancer Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels for the Years 2012, 2021 & 2027 |
| REST OF EUROPE |
| Rest of Europe Recent Past, Current & Future Analysis for Prostate Cancer Therapeutics by Therapy Type - Hormone Therapy, Targeted Therapy and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Prostate Cancer Therapeutics by Therapy Type - Hormone Therapy, Targeted Therapy and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Prostate Cancer Therapeutics by Therapy Type - Percentage Breakdown of Value Sales for Hormone Therapy, Targeted Therapy and Chemotherapy for the Years 2012, 2021 & 2027 |
| Rest of Europe Recent Past, Current & Future Analysis for Prostate Cancer Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Prostate Cancer Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Prostate Cancer Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels for the Years 2012, 2021 & 2027 |
| ASIA-PACIFIC |
| Prostate Cancer Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E) |
| Asia-Pacific Recent Past, Current & Future Analysis for Prostate Cancer Therapeutics by Therapy Type - Hormone Therapy, Targeted Therapy and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Prostate Cancer Therapeutics by Therapy Type - Hormone Therapy, Targeted Therapy and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Prostate Cancer Therapeutics by Therapy Type - Percentage Breakdown of Value Sales for Hormone Therapy, Targeted Therapy and Chemotherapy for the Years 2012, 2021 & 2027 |
| Asia-Pacific Recent Past, Current & Future Analysis for Prostate Cancer Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Prostate Cancer Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Prostate Cancer Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels for the Years 2012, 2021 & 2027 |
| REST OF WORLD |
| Rest of World Recent Past, Current & Future Analysis for Prostate Cancer Therapeutics by Therapy Type - Hormone Therapy, Targeted Therapy and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of World Historic Review for Prostate Cancer Therapeutics by Therapy Type - Hormone Therapy, Targeted Therapy and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of World 15-Year Perspective for Prostate Cancer Therapeutics by Therapy Type - Percentage Breakdown of Value Sales for Hormone Therapy, Targeted Therapy and Chemotherapy for the Years 2012, 2021 & 2027 |
| Rest of World Recent Past, Current & Future Analysis for Prostate Cancer Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of World Historic Review for Prostate Cancer Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of World 15-Year Perspective for Prostate Cancer Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels for the Years 2012, 2021 & 2027 |
| IV. COMPETITION |
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com